Real World Evidence Benefits, Limits Explored In US FDA Demonstrations

FDA's Jacqueline Corrigan-Curay lists three demonstrations now underway that are aimed at looking at different aspects of generating real world evidence and may inform the agency's evaluation of the data and methods.